Bortezomib Completed Phase 3 Trials for Multiple Myeloma (MM) / Effects of Chemotherapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03402295Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation